Bioimpedance Measurements on Human Neural Stem Cells as a Benchmark for the Development of Smart Mobile Biomedical Applications

Over the past 30 years, stem cell technologies matured from an attractive option to investigate neurodegenerative diseases to a possible paradigm shift in their treatment through the development of cell-based regenerative medicine (CRM). Implantable cell replacement therapies promise to completely restore function of neural structures possibly changing how we currently perceive the onset of these conditions. One of the major clinical hurdles facing the routine implementation of stem cell therapy is the limited and inconsistent benefit observed thus far. While unclear, numerous pre-clinical and a handful of clinical cell fate imaging studies point to poor cell retention and survival. Coupling the need to better understand these mechanisms while providing scalable approaches to monitor these treatments in both pre-clinical and clinical scenarios, we show a proof of concept bioimpedance electronic platform for the Agile development of smart and mobile biomedical applications like neural implants or highly portable monitoring devices.

[1]  Evgenios Neofytou,et al.  Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review. , 2016, JAMA cardiology.

[2]  Sarah Pönick,et al.  Impedance spectroscopy based measurement system for quantitative and label-free real-time monitoring of tauopathy in hippocampal slice cultures. , 2012, Biosensors & bioelectronics.

[3]  Alberto Martínez-Serrano,et al.  Generation and properties of a new human ventral mesencephalic neural stem cell line. , 2009, Experimental cell research.

[4]  Victoria Moreno-Manzano,et al.  Challenges of Stem Cell Therapy for Spinal Cord Injury: Human Embryonic Stem Cells, Endogenous Neural Stem Cells, or Induced Pluripotent Stem Cells? , 2009, Stem cells.

[5]  John H T Luong,et al.  On‐Line Monitoring of Cell Growth and Cytotoxicity Using Electric Cell‐Substrate Impedance Sensing (ECIS) , 2003, Biotechnology progress.

[6]  Alberto Martínez-Serrano,et al.  In Vitro and in Vivo Enhanced Generation of Human A9 Dopamine Neurons from Neural Stem Cells by Bcl-XL* , 2010, The Journal of Biological Chemistry.

[7]  Alberto Martínez-Serrano,et al.  Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl‐xL and reduced oxygen tension , 2009, Journal of neurochemistry.

[8]  Jan Tønnesen,et al.  Functional properties of the human ventral mesencephalic neural stem cell line hVM1 , 2010, Experimental Neurology.

[9]  Marc Peschanski,et al.  Impedimetric real-time monitoring of neural pluripotent stem cell differentiation process on microelectrode arrays. , 2016, Biosensors & bioelectronics.

[10]  Heinz-Georg Jahnke,et al.  A novel organotypic tauopathy model on a new microcavity chip for bioelectronic label-free and real time monitoring. , 2010, Biosensors & bioelectronics.

[11]  J Jossinet,et al.  Tissue impedance: a historical overview. , 1995, Physiological measurement.

[12]  T. Hug,et al.  Biophysical methods for monitoring cell-substrate interactions in drug discovery. , 2003, Assay and drug development technologies.

[13]  E. Snyder,et al.  Establishment and Properties of a Growth Factor-Dependent, Perpetual Neural Stem Cell Line from the Human CNS , 2000, Experimental Neurology.

[14]  Sabine Schmidt,et al.  Real-time monitoring of relaxation and contractility of smooth muscle cells on a novel biohybrid chip. , 2010, Lab on a chip.

[15]  Nils Blüthgen,et al.  Analysis of impedance-based cellular growth assays , 2015, Bioinform..

[16]  Claudia Caviglia,et al.  High temperature SU-8 pyrolysis for fabrication of carbon electrodes , 2017 .